Epidemiological Specificity оf COVID-19 Comorbidity
https://doi.org/10.47619/2713-2617.zm.2023.v.4i4;15-22
Abstract
Numerous observations have proven the influence of COVID-19 on the formation of comorbid pathology; however, the patterns of this relationship and the epidemiological consequences have not been sufficiently studied. Combination of two or more diseases of the cardiovascular system is a predictor of adverse outcomes in stroke patients with coronavirus infection, both in the acute period and after hospitalization. Ischemic stroke in patients with COVID-19 is associated with an increased risk of severe post-covid syndrome. The negative impact of the obligatory lockdown on disease outcomes has encouraged the authors to search for new organizational solutions as well as to elaborate appropriate technologies aimed at optimizing medical and social care for people who had no choice but to follow lockdown rules. Obligatory self-isolation, anxiety-depressive disorders, and frequent negative outcomes among these patients require the adoption of new organizational decisions and the development of effective technologies aimed at optimizing medical and social care. The authors conducted an analytical analysis of post-infectious complications in patients with ischemic stroke complicated by COVID-19. The authors conducted a combined retrospective study. Measures for improvement of medical care in stroke patients with concurrent COVID-19 were presented.
About the Authors
E. N. KabaevaRussian Federation
Kabaeva Ekaterina Nikolaevna – Candidate of Medical Sciences, Associate Professor of the Department of Neurology and Geriatrics
12, bldg. 1, Vorontsovo Pole ul., Moscow, 105064;
6 Miklukho-Maklaya ul., Moscow, 117198
M. A. Yakushin
Russian Federation
Yakushin Mikhail Alexandrovich – Doctor of Medical Sciences, Associate Professor, Chief Specialist in Geriatrics of the Ministry of Health of the Moscow Region, Leading Researcher
12, bldg. 1, Vorontsovo Pole ul., Moscow, 105064;
9 Sharikopodshipnikovskaya ul., Moscow, 115088;
10A Radio ul., Moscow, 105005
A. V. Vorobeva
Russian Federation
Vorobeva Anna Vladimirovna – graduate student
12, bldg. 1, Vorontsovo Pole ul., Moscow, 105064
M. D. Vasiliev
Russian Federation
Vasiliev Mikhail Dmitrievich – Candidate of Medical Sciences, researcher at the Research Institute
12, bldg. 1, Vorontsovo Pole ul., Moscow, 105064;
9 Sharikopodshipnikovskaya ul., Moscow, 115088
O. Yu. Arseenkova
Russian Federation
Arseenkova Olga Yu. – Candidate of Medical Sciences, Senior Researcher
12, bldg. 1, Vorontsovo Pole ul., Moscow, 105064;
9 Sharikopodshipnikovskaya ul., Moscow, 115088
References
1. Lu R., Zhao X., Li J., Niu P., Yang B., Wu H. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding // J. Lancet. 2020;395(10224):565–74. DOI: 10.1016/S0140-6736(20)30251-8.
2. Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China // J. JAMA Neurol. 2020;77(6):683–90. DOI:10.1001/jamaneurol.2020.112
3. Romero-Sánchez C. M., Díaz-Maroto I., Fernández-Díaz E., Sánchez-Larsen Á., Layos-Romero A., GarcíaGarcía J. et al. Neurologic manifestations in hospitalized patients with covid-19 // J. Neurology. 2020;95(8): 1060–1070. DOI: 10.1212/WNL.0000000000009937
4. Trejo-Gabriel-Galán J.M. Stroke as a complication and prognostic factor of COVID-19 // J. Neurologia. 2020;35(5):318–22. DOI: 10.1016/j.nrl.2020.04.015
5. Carod-Artal F.J. Neurological complications of coronavirus and COVID-19 // J. Rev Neurol. 2020;70(9):311–22. DOI: 10.33588/rn.7009.2020179
6. Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á, Martínez-Cava A, Franco-López F, Sánchez-Alcaraz Martínez BJ. et al. Post-COVID-19 Syndrome and the Potential Benefits of Exercise // J. Environ Res Public Health. 2021 May 17;18(10):5329. doi: 10.3390/ijerph18105329
7. Camargo-Martínez W, Lozada-Martínez I, Escobar-Collazos A, Navarro-Coronado A, Moscote-Salazar L, Pacheco-Hernández A. et al. Post-COVID 19 neurological syndrome: Implications for sequelae's treatment // J. ClinNeurosci. 2021 Jun;88:219-225. doi: 10.1016/j.jocn.2021.04.001
8. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments // J. Infect Dis. 2021 Oct;53(10):737-754. doi: 10.1080/23744235.2021.1924397
9. Ortelli P, Ferrazzoli D, Sebastianelli L, Engl M, Romanello R, Nardone R. et al. Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom // J. Neurol Sci. 2021 Jan 15;420:117271. doi: 10.1016/j.jns.2020.117271
10. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A. et al. COVID-19 and cardiovascular disease // J. Circulation. 2020;141(20):1648–55. DOI: 10.1161/CIRCULATIONAHA.120.046941
11. Castro R.A., Frishman W.H. Thrombotic complications of COVID-19 infection: A review // J. Cardiol Rev. 2021;29(1):43–7. DOI: 10.1097/CRD.0000000000000347
12. Sagris D, Papanikolaou A, Kvernland A, Korompoki E, Frontera JA, Troxel AB. et al. COVID-19 and ischemic stroke // J. Neurol. 2021 Nov;28(11):3826-3836. doi: 10.1111/ene.15008
Review
For citations:
Kabaeva E.N., Yakushin M.A., Vorobeva A.V., Vasiliev M.D., Arseenkova O.Yu. Epidemiological Specificity оf COVID-19 Comorbidity. City Healthcare. 2023;4(4):15-22. (In Russ.) https://doi.org/10.47619/2713-2617.zm.2023.v.4i4;15-22